Skip to main content

Muscular Dystrophy and cannabis in Montana

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
1 oz usable cannabis un…
POSSESSION
$5/yr
STATE FEE
5–14 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Montana statute and program

The Montana Medical Marijuana Program is the operating authority for Montana patient certification. The authoritative legal text is: Montana Code Annotated Title 16 Chapter 12: Marijuana Regulation and Taxation Act. The program portal is at Montana Medical Marijuana Program.

What the evidence says about cannabis and Muscular Dystrophy

Muscular dystrophy refers to a group of more than 30 inherited genetic disorders characterized by progressive muscle weakness and degeneration caused by mutations in genes encoding proteins that maintain muscle-fiber integrity. The major clinical subtypes include:

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Muscular Dystrophy page.

How to qualify in Montana

The Montana Medical Marijuana Program requires the following registration steps for a Muscular Dystrophy patient (or any qualifying diagnosis):

  1. Get certified by a Montana-licensed physician. Under Mont. Code Ann. §50-46-301 et seq. (Montana Marijuana Regulation and Taxation Act, voters approved 2004 and modernized 2021), any Montana-licensed MD, DO, advanced practice registered nurse, or physician assistant authorized to prescribe controlled substances may certify a patient. Qualifying debilitating medical conditions include cancer, glaucoma, HIV/AIDS, MS, epilepsy, intractable nausea, severe chronic pain, cachexia, severe muscle spasms, PTSD, Crohn’s, central nervous system disorders, painful peripheral neuropathy, and admittance to hospice care.
  2. Apply through the Montana DPHHS portal. The patient creates an account in the Montana Department of Public Health and Human Services (DPHHS) Cannabis Control Division registry portal, uploads the physician certification, a Montana driver license or state ID, and a passport-style photograph. Caregivers (called "providers" under Montana law) register separately and pass a state background check.
  3. Pay the $5 state registration fee. The annual Montana medical marijuana registry card fee is $5 — among the lowest in the United States. Patients pay only this nominal state fee plus the physician certification fee. Caregivers pay a separate higher provider licensing fee through the Cannabis Control Division.
  4. Receive the card and purchase from a Montana dispensary. Montana medical marijuana registry cards are typically issued within 5 to 10 business days of complete application. Patients may purchase up to 5 ounces of usable cannabis per month from any of the licensed Montana medical dispensaries and may cultivate up to 4 mature plus 4 seedling plants. Adult-use retail launched January 1, 2022 under HB 701 (2021); medical patients retain the lower 4% medical tax versus the 20% adult-use rate and access to higher-potency products.
State registration fee
$5
Physician visit (typical)
$150–$300
Certification to card
5–14 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Montana registration steps, fees, and reciprocity rules, see the Montana cannabis-laws page.

ICD-10 code

A certifying physician documenting Muscular Dystrophy for the Montana medical cannabis program will typically record ICD-10 G71.0 or SNOMED-CT 76670001 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Montana list Muscular Dystrophy as a qualifying condition for medical cannabis?

No. Montana's qualifying-condition list does not currently include Muscular Dystrophy, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Muscular Dystrophy in Montana have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Montana program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a Montana medical marijuana card for Muscular Dystrophy?

Because Montana does not currently list Muscular Dystrophy as a qualifying condition, a card for Muscular Dystrophy alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Montana who is registered with Montana Medical Marijuana Program and willing to evaluate Muscular Dystrophy cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Montana does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Montana Medical Marijuana Program site at https://dphhs.mt.gov/marijuana; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Muscular Dystrophy?

For Muscular Dystrophy, evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Muscular Dystrophy lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Muscular Dystrophy should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Muscular Dystrophy and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Muscular Dystrophy; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Montana Code Annotated Title 16 Chapter 12: Marijuana Regulation and Taxation Actaccessed May 16, 2026
  2. Montana Department of Revenue: Cannabis Control Divisionaccessed May 16, 2026
  3. Montana Department of Public Health and Human Services: Medical Marijuana Programaccessed May 16, 2026
  4. Wikipedia: Cannabis in Montanaaccessed May 16, 2026
  5. NIH National Institute of Neurological Disorders and Stroke: Muscular Dystrophyaccessed May 18, 2026
  6. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 18, 2026

    “Substantial evidence that oral cannabinoids are effective antiemetics in the treatment of chemotherapy-induced nausea.”

  7. Muscular Dystrophy Association: About Neuromuscular Diseasesaccessed May 18, 2026
  8. MedlinePlus: Muscular dystrophyaccessed May 18, 2026
  9. FDA: Epidiolex (cannabidiol) prescribing informationaccessed May 18, 2026